Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Data by

Global Data

Mylan

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Mylan's 2012 sales performance.

With US approval, GSK now needs rapid uptake for COPD triple

With US approval, GSK now needs rapid uptake for COPD triple

Generic drugmakers Hikma and Mylan have both tried to bring Advair generics to market but have been blocked at the final hurdle, while Novartis' subsidiary Sandoz filed for its version of

Amgen's Mvasi is first FDA-approved cancer biosimilar

Amgen's Mvasi is first FDA-approved cancer biosimilar Mvasi reaches the market ahead of rival Avastin biosimilars from Boehringer Ingelheim, Samsung Bioepis, Pfizer and Biocon/Mylan that are all in late-stage development. ... Mylan is expecting to hear from the FDA before the end of the month.

Life lessons

Life lessons But today, with dire news from Sandoz, Mylan, Teva and many other generic players, their model seems to be fading.

Biocon backs away from biosimilar filings in Europe

Biocon backs away from biosimilar filings in Europe At the time, it said that along with partner Mylan it would "work with the French and European. ... Mylan has agreed a settlement deal with Roche to clear the way for a US launch if approved by the FDA.

People at-risk of HIV in England could get PrEP from September

People at-risk of HIV in England could get PrEP from September PrEP. It has reached an agreement on the supply of a generic version of Truvada from Mylan that will allow it to keep the cost of the trial down to £10m

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Global Data Data by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
FCB Halesway

A Eureka moment! A converted dairy in the Hampshire countryside back in 1993 saw the inception of Halesway as a...

Latest intelligence

robot
AI’s potential in the pharma life cycle
At a time that the future of life sciences is being hotly debated, the opportunity for the industry to refine and expand its role is an important one to take...
OUTiCO Case Study - Product Launch
POSITIVE FORMULARY SUCCESS WITHIN 8 MONTHS!...
An insight into Multi-Channel Account Management
At OUTiCO we often talk about moving away from traditional methods, embracing change, and offering an exceptional outsourcing service, but what does that mean day to day?...

Infographics